Pre-transplant level of soluble CD30 is associated with infection after heart transplantation

Clinical Transplantation

Volumn 21, Issue 6, 2007, Pages 744-747

  Nikaein, Afzal ^a   Spiridon, Camelia ^a,c   Hunt, Judson ^b   Rosenthal, Jed ^b   Anderson, Allan ^b   Eichhorn, Erick ^b   Magee, Mitchell ^b   Dewey, Todd ^b   Mack, Michael ^b  

^a Texas Medical Specialty Inc   (United States)

^b MEDICAL CITY DALLAS HOSPITAL   (United States)

^c NONE   (United States)

Author keywords

Heart transplantation; Immunology; Soluble CD30

Indexed keywords

CD30 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD30; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; CORRELATIONAL STUDY; DEATH; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION RISK; LENGTH OF STAY; MAJOR CLINICAL STUDY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; RISK ASSESSMENT; TREATMENT OUTCOME;

CD30 LIGAND; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNITY, CELLULAR; INCIDENCE; INFECTION; PROGNOSIS; T-LYMPHOCYTES; TEXAS;

EID: 35848943901     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2007.00732.x     Document Type: Article

References (20)

1. Claas FJH, Van Leewen A, Van Rood J. Hyperimmunized patients do not need to wait for an HLA identical donor. Tissue Antigens 1999: 34: 23.
2. Laundy GL, Bradley BA. The predictive value of epitope analysis in highly sensitised patients awaiting renal transplantation. Transplantation 1995: 59: 1207.
3. Gebel HM, Brag RA. Sensitization and sensitivity. Defining unsensitized patients. Transplantation 2000: 69: 1370.
4. Kerman R, Orosz C, Lorber M. Clinical relevance of anti-HLA antibodies pre and post transplant. Am J Med Sci 1997: 313: 275.
5. Aizawa S, Nakano H, Horie R et al. Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF 2 are involved in CD30-mediated NF-kappa-B activation. J Biol Chem 1997: 272: 2042.
6. Soo YL, Sang YL, Gokul K, Mei-Ling L, Hsiou-Chi L, Yong C. CD30/TNF receptor associated factor interaction: NF-kB activation and binding specificity. Proc Natl Acad Sci USA 1996: 93: 9699.
7. Martinez Olivia M, Villanueva J, Abtahi S et al. CD30 expression identifies a functional alloreactive human T lymphocyte subset. Transplantation 1998: 65: 1240.
8. Schneider C, Hubinger G. Pleiotropic signal transduction mediated by human CD30: A member of the tumor necrosis factor receptor (TNFR) family. Leuk Lymphoma 2002: 43: 1355.
9. Ansieau S, Scheffrahn I, Mosialos G et al. Tumor necrosis factor receptor-associated factor (TRAF)1, TRAF-2. Proc Natl Acad Sci USA 1996: 93: 14053.
10. H iromi M, L awrence HB, L ei F, E ckhard RP. CD30 signals integrate expression of cytotoxic effector molecules, lymphocyte trafficking signals, and signals for proliferation and apoptosis. J Immunol 2000: 165: 5105.
11. Susal C, Pelzl S, Opelz G. Strong human leukocyte antigen matching effect in nonsensitized kidney recipients with high pretransplant soluble CD30. Transplantation 2002: 76: 1231.
12. Bertollo A, Vagliasindi C, Gerli R et al. Soluble CD30 antigen in human colostrum. Biol Neonate 1997: 71: 69.
13. Frisaldi E, Conca R, Magistroni P et al. Prognostic values of soluble CD30 and CD30 gene polimorphisms in heart transplantation. Transplantation 2006: 81: 1153.
14. Bauwens AM, van de Graaf EA, van Ginkel WG, van Kessel DA, Otten HG. Pre-transplant soluble CD30 is associated with bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 2006: 25: 416.
15. Ostensen M, Forger F, Nelson JL, Schuhmacher A, Hebisch G, Villiger PM. Pregnancy in patients with rheumatic disease: Anti-inflammatory cytokines increase in pregnancy and decrease post partum. Ann Rheum Dis 2005: 64: 801.
16. A gresti A. A survey of exact inference for contingency tables. Stat Sci 1992: 7: 131.
17. Michaels P, Espejo ML, Kobashigawa J, Alejos JC, Burch C, Takemoto S. Humoral rejection in cardiac transplantation: Risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant 2003: 22: 58.
18. Strom TB, Roy-Chaudhury P, Manfro R et al. The Th1/Th2 paradigm and the allograft response. Curr Opin Immunol 1996: 8: 688.
19. Kim KH, Oh EJ, Jung ES et al. Evaluation of pre and posttransplantation serum interferon-gamma and soluble CD30 for predicting liver allograft rejection. Transplant Proc 2006: 38: 1429.
20. Weimer R, Zipperle S, Daniel V, Carl S, Staehler G, Opelz G. Pretransplant CD4 helper function and interleukin 10 response predict risk of acute kidney graft rejection. Transplantation 1996: 62: 1606.